Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human VCP ELISA Kit (AC2978)
Cat.#: ASET-1567
Specifications
Description Human VCP ELISA Kit allows for the in vitro quantitative determination of human VCP concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1176 Human CD97 ELISA Kit (AC2587) Quantitative inquiry ASET-2313 Human Neuropeptide Y ELISA Kit (AC3724) Quantitative inquiry ASET-1256 Mouse Leptin ELISA Kit (AC2667) Quantitative inquiry ASET-2076 Human EDG8 ELISA Kit (AC3487) Quantitative inquiry ASET-1346 Mouse Chromogranin B ELISA Kit (AC2757) Quantitative inquiry ASET-2533 Human Creatine Kinase B Type ELISA Kit (AC3944) Quantitative inquiry ASET-1860 Human NR1D1 ELISA Kit (AC3271) Quantitative inquiry ASET-1681 Mouse p75 NGF Receptor ELISA Kit (AC3092) Quantitative inquiry ASET-1417 Mouse Adenosine Receptor A2a ELISA Kit (AC2828) Quantitative inquiry ASET-1806 Human Butyrylcholinesterase ELISA Kit (AC3217) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket